Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Lengauer

Thomas Lengauer, director at the Max Planck Institute for Informatics in Saarbrücken, has been elected as the next president of the International Society for Computational Biology (ISCB). He will take office as president-elect of the ISCB in January 2017 and will officially become president of the society in January 2018 taking over from current ISCB president Alfonso Valencia. Lengauer's term will end in January 2021. Lengauer will be the seventh president of the ISCB. He is a founding member of the society and currently serves as its vice president. He was named an ISCB fellow in 2015. He holds two doctoral degrees, one in mathematics from the Free University of Berlin, and one in computer science from Stanford University. His research interests lie in the field computational epigenomics, specifically, in understanding viral drug resistance. His lab has developed software that is used to select drug combinations for HIV patients.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.